[{"AccountsPayableAndOtherAccruedLiabilitiesCurrent_0_Q3_USD":3289000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":236000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":19000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":11000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3_Q3_USD":-160000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":8000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":751000.0,"OperatingLeaseRightOfUseAssetAmortizationExpense_3_Q3_USD":5000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":3743000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":3273000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":475000.0,"OperatingLeaseLiability_0_Q3_USD":3748000.0,"OperatingLeaseCost_3_Q3_USD":400000.0,"OperatingLeaseCost_1_Q3_USD":200000.0,"OperatingIncomeLoss_3_Q3_USD":-24704000.0,"OperatingIncomeLoss_1_Q3_USD":-11337000.0,"OperatingExpenses_3_Q3_USD":24704000.0,"OperatingExpenses_1_Q3_USD":11337000.0,"NetIncomeLoss_3_Q3_USD":-24468000.0,"NetIncomeLoss_1_Q3_USD":-11318000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-20150000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-3585000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":379018000.0,"MarketableSecuritiesCurrent_0_Q3_USD":36056000.0,"PaymentsToAcquireInvestments_3_Q3_USD":36356000.0,"LiabilitiesCurrent_0_Q3_USD":5505000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":1184000.0,"PrepaidExpenseCurrent_0_Q3_USD":1421000.0,"TemporaryEquitySharesOutstanding_0_Q3_shares":0.0,"TemporaryEquitySharesIssued_0_Q3_shares":0.0,"TemporaryEquitySharesAuthorized_0_Q3_shares":0.0,"TemporaryEquityParOrStatedValuePerShare_0_Q3_USD":0.0001,"TemporaryEquityLiquidationPreference_0_Q3_USD":0.0,"StockIssuedDuringPeriodValueNewIssues_3_Q3_USD":254271000.0,"StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_3_Q3_USD":170068000.0,"StockholdersEquity_0_Q3_USD":391564000.0,"ShareBasedCompensation_3_Q3_USD":3133000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-36391000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":17441000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":8539000.0,"RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty_3_Q3_USD":202000.0,"RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty_1_Q3_USD":82000.0,"RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_3_Q3_USD":188000.0,"RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_1_Q3_USD":98000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":1320000.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":1372000.0,"ProfitLoss_3_Q3_USD":-24468000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_3_Q3_USD":33955000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_3_Q3_USD":35000.0,"ProceedsFromIssuanceOfConvertiblePreferredStock_3_Q3_USD":124712000.0,"ProceedsFromIssuanceInitialPublicOffering_3_Q3_USD":254271000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":1572000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":55155030.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":400353000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":886000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":355283000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":357662000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":357662000.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":112000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q3_USD":36056000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q3_USD":36060000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q3_USD":5000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":1000.0,"AssetsCurrent_0_Q3_USD":395290000.0,"Assets_0_Q3_USD":400353000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":2569986.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":3133000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":1243000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3_Q3_USD":3133000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":1243000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":427953000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":-4000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":52000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":3289000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_3_Q3_USD":103000.0,"AccountsPayableRelatedPartiesCurrent_0_Q3_USD":20000.0,"AccountsPayableCurrent_0_Q3_USD":2216000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"Liabilities_0_Q3_USD":8789000.0,"CommonStockSharesAuthorized_0_Q3_shares":200000000.0,"CommonStockSharesOutstanding_0_Q3_shares":55224420.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":181000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":755000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":778000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":801000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":733000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":4634000.0,"InvestmentsFairValueDisclosure_0_Q3_USD":392848000.0,"InterestReceivableCurrent_0_Q3_USD":47000.0,"InterestExpenseRelatedParty_3_Q3_USD":0.0,"InterestExpenseRelatedParty_1_Q3_USD":0.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":1158000.0,"IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_3_Q3_USD":2444000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":7263000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":2798000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":1411000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-0.57,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.21,"Depreciation_3_Q3_USD":47000.0,"DepositsAssetsCurrent_0_Q3_USD":104000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_0_Q3_Security":19.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-24628000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-11310000.0,"CommonStockValue_0_Q3_USD":6000.0,"CommonStockSharesIssued_0_Q3_shares":55654833.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":42759656.0,"Ticker":"DSGN","CIK":"1807120","name":"DESIGN THERAPEUTICS, INC.","OfficialName":"Design Therapeutics Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"802639248.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211109"}]